Influenza causes a major public health burden, as evidenced by the tremendous efforts required to prevent and treat disease during the recent H1N1 pandemic. The primary influenza prevention method is vaccination;however, the effectiveness of influenza vaccine varies depending upon host factors and vaccine characteristics that include individual immune response and the match between the vaccine strains and circulating strains in any given year. Therefore, vaccine effectiveness (VE) varies annually, particularly among elderly persons, and is a subject of international controversy. We propose an age-matched case-control study of the effectiveness of influenza vaccine in the UPMC- Health System. Using case-control methods, we propose to calculate the effectiveness of influenza vaccines against laboratory-confirmed influenza virus infections among outpatients in three age groups: 6 months-18 yrs, 19-49 yrs, and 50+yrs. We will use existing syndromic surveillance to identify when influenza-like illness (ILI) begins in the community;recruit, consent and enroll outpatients with for medically-attended acute respiratory illness (MAARI);test with reverse transcriptase-polymerase chain reaction (RT-PCR) to identify cases and controls;determine vaccination status using primarily the UPMC electronic health record (EHR) and the electronic statewide vaccine registry (PA-SIIS);quantify potential confounders and effect modifiers using the EHR (e.g., Charleson co-morbidity score) and survey methodology;determine VE;and conduct sensitivity analyses about the impact of potential unmeasured confounders. Additionally we will determine the local epidemiology, burden and course of influenza illness and estimate the population-based attack rate for laboratory-confirmed influenza, using agent-based modeling at the Pittsburgh Supercomputing Center. The proposed study is based on a strong foundation of our ongoing syndromic surveillance of influenza, advanced biomedical informatics using system-wide electronic medical record, broadly-based research to increase vaccination rates, clinical context of multiplex respiratory virus testing, and agent-based modeling to produce population estimates of disease burden and cost and involves a well-published team of investigators.
The effectiveness of influenza vaccine is controversial due to lack of laboratory- confirmed endpoints and confounding. We propose a case-control study in the UPMC Health System comparing the effectiveness of influenza vaccine against laboratory- confirmed influenza among children and adults who present for care, comparing vaccination status and adjusting for confounders. Agent based modeling will be used for evaluate population disease burden. Real-time disease surveillance will be used to track the influenza season.
|Havers, Fiona; Thaker, Swathi; Clippard, Jessie R et al. (2014) Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season. Clin Infect Dis 59:774-82|
|Ohmit, Suzanne E; Thompson, Mark G; Petrie, Joshua G et al. (2014) Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 58:319-27|
|Ross, Ted M; Lin, Chyongchiou Jeng; Nowalk, Mary Patricia et al. (2014) Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age. Hum Vaccin Immunother 10:1195-203|